Brief: Abcellera And Everest Medicines Announce Multi-Target Collaboration

Everest Medicines

22/09/2021 23:02

Sept 22 (Reuters) - Everest Medicines Ltd  1952.HK :
    * ABCELLERA AND EVEREST MEDICINES ANNOUNCE MULTI-TARGET
COLLABORATION TO ADVANCE NEW ANTIBODY THERAPIES
    * ABCELLERA - 10-TARGET PARTNERSHIP LEVERAGES CO'S
TECHNOLOGY TO
ACCELERATE EVEREST'S PIPELINE OF NOVEL, INNOVATIVE MEDICINES TO
PATIENTS
    * ABCELLERA BIOLOGICS INC - EVEREST WILL HAVE RIGHTS TO
DEVELOP
AND COMMERCIALIZE ANTIBODIES RESULTING FROM COLLABORATION
    * ABCELLERA BIOLOGICS INC - WILL RECEIVE RESEARCH PAYMENTS
AND IS
ELIGIBLE TO RECEIVE FROM EVEREST MILESTONE PAYMENTS AND
ROYALTIES ON SALES OF PRODUCTS

Source text for Eikon:  ID:nPn48RpkZa 
Further company coverage:  1952.HK 

 ((Reuters.Briefs@thomsonreuters.com;))